Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred Zippelius

Showing results (101-110 of 163) with videos related to

Pageof 17
Sort By:
Cancer Immunology Research|August 9, 2015
Progression of Lung Cancer Is Associated with Increased Dysfunction of T Cells Defined by Coexpression of Multiple Inhibitory ReceptorsDaniela S Thommen, Jens Schreiner, Philipp Müller, et al.
Cancer Immunology Research|April 17, 2019
Siglec-9 Regulates an Effector Memory CD8<sup>+</sup> T-cell Subset That Congregates in the Melanoma Tumor MicroenvironmentQuentin Haas, Kayluz Frias Boligan, Camilla Jandus, et al.
Cancer Immunology Research|August 22, 2020
Hyperglycemia Enhances Cancer Immune Evasion by Inducing Alternative Macrophage Polarization through Increased O-GlcNAcylationNatália Rodrigues Mantuano, Michal A Stanczak, Isadora de Araújo Oliveira, et al.
Nature|June 3, 2021
Hepatic stellate cells suppress NK cell-sustained breast cancer dormancyAna Luísa Correia, Joao C Guimaraes, Priska Auf der Maur, et al.
Clinical Lung Cancer|December 21, 2016
Bevacizumab Plus Pemetrexed Versus Pemetrexed Alone as Maintenance Therapy for Patients With Advanced Nonsquamous Non-Small-cell Lung Cancer: Update From the Swiss Group for Clinical Cancer Research (SAKK) 19/09 TrialOliver Gautschi, Sacha I Rothschild, Qiyu Li, et al.
Journal for Immunotherapy of Cancer|January 23, 2019
A novel anti-HER2 anthracycline-based antibody-drug conjugate induces adaptive anti-tumor immunity and potentiates PD-1 blockade in breast cancerLucia D'Amico, Ulrike Menzel, Michael Prummer, et al.
Science Translational Medicine|September 17, 2025
PD-1-targeted cis-delivery of an IL-2 variant induces a multifaceted antitumoral T cell response in human lung cancerIrene Fusi, Clara Serger, Petra Herzig, et al.
Nature|November 12, 2021
Author Correction: Hepatic stellate cells suppress NK cell-sustained breast cancer dormancyAna Luísa Correia, Joao C Guimaraes, Priska Auf der Maur, et al.
Nature Biomedical Engineering|June 29, 2026
The evolving role of cytokines for CAR-T cell manufacturing and beyondMar Guaza-Lasheras, Johanna Nimmerfroh, Dominic Schwarz, et al.
Cancers|May 28, 2022
Effects of COVID-19 Lockdown on Melanoma Diagnosis in Switzerland: Increased Tumor Thickness in Elderly Females and Shift towards Stage IV Melanoma during LockdownLisa Kostner, Sara Elisa Cerminara, Gustavo Santo Pedro Pamplona, et al.
Pageof 17

Showing results (101-110 of 163) with videos related to

Sort By:
Pageof 17
Cancer Immunology Research|August 9, 2015
Progression of Lung Cancer Is Associated with Increased Dysfunction of T Cells Defined by Coexpression of Multiple Inhibitory ReceptorsDaniela S Thommen, Jens Schreiner, Philipp Müller, et al.
Cancer Immunology Research|April 17, 2019
Siglec-9 Regulates an Effector Memory CD8<sup>+</sup> T-cell Subset That Congregates in the Melanoma Tumor MicroenvironmentQuentin Haas, Kayluz Frias Boligan, Camilla Jandus, et al.
Cancer Immunology Research|August 22, 2020
Hyperglycemia Enhances Cancer Immune Evasion by Inducing Alternative Macrophage Polarization through Increased O-GlcNAcylationNatália Rodrigues Mantuano, Michal A Stanczak, Isadora de Araújo Oliveira, et al.
Nature|June 3, 2021
Hepatic stellate cells suppress NK cell-sustained breast cancer dormancyAna Luísa Correia, Joao C Guimaraes, Priska Auf der Maur, et al.
Clinical Lung Cancer|December 21, 2016
Bevacizumab Plus Pemetrexed Versus Pemetrexed Alone as Maintenance Therapy for Patients With Advanced Nonsquamous Non-Small-cell Lung Cancer: Update From the Swiss Group for Clinical Cancer Research (SAKK) 19/09 TrialOliver Gautschi, Sacha I Rothschild, Qiyu Li, et al.
Journal for Immunotherapy of Cancer|January 23, 2019
A novel anti-HER2 anthracycline-based antibody-drug conjugate induces adaptive anti-tumor immunity and potentiates PD-1 blockade in breast cancerLucia D'Amico, Ulrike Menzel, Michael Prummer, et al.
Science Translational Medicine|September 17, 2025
PD-1-targeted cis-delivery of an IL-2 variant induces a multifaceted antitumoral T cell response in human lung cancerIrene Fusi, Clara Serger, Petra Herzig, et al.
Nature|November 12, 2021
Author Correction: Hepatic stellate cells suppress NK cell-sustained breast cancer dormancyAna Luísa Correia, Joao C Guimaraes, Priska Auf der Maur, et al.
Nature Biomedical Engineering|June 29, 2026
The evolving role of cytokines for CAR-T cell manufacturing and beyondMar Guaza-Lasheras, Johanna Nimmerfroh, Dominic Schwarz, et al.
Cancers|May 28, 2022
Effects of COVID-19 Lockdown on Melanoma Diagnosis in Switzerland: Increased Tumor Thickness in Elderly Females and Shift towards Stage IV Melanoma during LockdownLisa Kostner, Sara Elisa Cerminara, Gustavo Santo Pedro Pamplona, et al.
Pageof 17